Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Take action against chemists selling prescription drugs OTC sans authorization: HC directs Govt

      Take action against chemists selling prescription drugs OTC sans authorization: HC directs Govt

      Medical Dialogues Bureau7 Dec 2019 10:07 AM IST
      The petition had alleged that chemists dealing in the retail sale of medicines are selling antibiotics and medicines mentioned in Schedule H and H1 of...
      Diabetes drug Metformin under USFDA lens for presence of cancer-causing impurities

      Diabetes drug Metformin under USFDA lens for presence of cancer-causing impurities

      Medical Dialogues Bureau7 Dec 2019 9:35 AM IST
      Metformin is a first-line medication for the treatment of type 2 diabetes. It helps control high blood sugar and is marketed under a number of brand...
      True North gets IRDAI nod to buy 51 pc stake in Max Bupa at enterprise value of Rs 1 crore

      True North gets IRDAI nod to buy 51 pc stake in Max Bupa at enterprise value of Rs 1 crore

      Medical Dialogues Bureau7 Dec 2019 9:30 AM IST
      The all-cash transaction announced in February 2019 valued Max Bupa at an enterprise value of Rs 1,001 crore, Max India said in a statement. New...
      Eli Lilly new cancer research unit Loxo Oncology to be run by Loxo executives

      Eli Lilly new cancer research unit Loxo Oncology to be run by Loxo executives

      Medical Dialogues Bureau7 Dec 2019 9:15 AM IST
      The new unit, to be called Loxo Oncology at Lilly, will include experimental cancer drugs from both Eli Lilly's and Loxo's developmental pipelines.New...
      Insurance coverage for CAR-T cell therapies from Novartis, Gilead get Swiss Govt nod

      Insurance coverage for CAR-T cell therapies from Novartis, Gilead get Swiss Govt nod

      Medical Dialogues Bureau7 Dec 2019 9:10 AM IST
      The health department said the decision covered Novartis's Kymriah and Gilead's Yescarta.New Delhi: The Swiss government approved on Friday health...
      Biogen builds case for its Alzheimers drug aducanumab, skeptics say more data needed

      Biogen builds case for its Alzheimers drug aducanumab, skeptics say more data needed

      Medical Dialogues Bureau7 Dec 2019 9:00 AM IST
      If approved, Biogen Inc's aducanumab would be the first treatment designed to delay the progression of the fatal, mind-robbing disease for millions of...
      Zydus Cadila files NDA with DCGI for liver disease drug Saroglitazar Magnesium

      Zydus Cadila files NDA with DCGI for liver disease drug Saroglitazar Magnesium

      Medical Dialogues Bureau6 Dec 2019 1:31 PM IST
      Saroglitazar Magnesium was launched in India during September 2013, for the treatment of hypertriglyceridemia and diabetic dyslipidemia in patients...
      Profitability of pharma firms unhurt by proposed cap on trade margins: Fitch

      Profitability of pharma firms unhurt by proposed cap on trade margins: Fitch

      Medical Dialogues Bureau6 Dec 2019 9:20 AM IST
      "India's proposal to cap trade margins...will not significantly hurt the profitability of pharmaceutical companies, as the proposal does not restrict...
      Shilpa Medicare Raichur facility gets EIR from USFDA

      Shilpa Medicare Raichur facility gets EIR from USFDA

      Medical Dialogues Bureau6 Dec 2019 9:15 AM IST
      The company announced successful closure of the inspection conducted at its active pharmaceutical ingredient (API) manufacturing site at Raichur with...
      Only Retail, NOT online pharmacies eligible to deliver medicines at a customer

      Only Retail, NOT online pharmacies eligible to deliver medicines at a customer's residence; Draft guidelines

      Medical Dialogues Bureau6 Dec 2019 9:09 AM IST
      Retail pharmacies still home deliver drugs in their respective areas, but if the revised regulations get enforced, they would be allowed to do in a...
      Roche Tecentriq immunotherapy cocktail wins USFDA approval for treating lung cancer

      Roche Tecentriq immunotherapy cocktail wins USFDA approval for treating lung cancer

      Medical Dialogues Bureau6 Dec 2019 9:00 AM IST
      The U.S. Food and Drug Administration approved Tecentriq mixed with Celgene's Abraxane and carboplatin chemotherapy to treat metastatic non-squamous...
      Bharat Biotech unveils oral rotavirus vaccine ROTAVAC 5D to protect against diarrhoea

      Bharat Biotech unveils oral rotavirus vaccine ROTAVAC 5D to protect against diarrhoea

      Medical Dialogues Bureau5 Dec 2019 4:40 PM IST
      Developed by Bharat Biotech, oral rotavirus vaccine ROTAVAC 5D is safe and effective in the prevention of rotavirus diarrhoea. ROTAVAC 5D can be...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok